MCID: HTL001
MIFTS: 35

Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Categories: Cancer diseases, Rare diseases

Aliases & Classifications for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

MalaCards integrated aliases for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis:

Name: Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis 53
Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/tropical Spastic Paraparesis 53
Tropical Spastic Paraparesis 73
Ham/tsp 53

Classifications:



External Ids:

UMLS 73 C0030481

Summaries for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

NIH Rare Diseases : 53 HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive disease of the nervous system that affects less than 2% of people with HTLV-1 infection. Signs and symptoms vary but may include slowly progressive weakness and spasticity of one or both legs, exaggerated reflexes, muscle contractions in the ankle, and lower back pain. Other features may include urinary incontinence and minor sensory changes, especially burning or prickling sensations and loss of vibration sense. The reason some people with HTLV-1 infection develop HAM/TSTP is not well understood. Treatment generally aims to control the specific symptoms, as there is no standard treatment available.Interferon alpha may be beneficial over short periods, and some aspects of the disease may be improved with interferon beta. Other medications may include immune globulin, oral corticosteroids, and muscle relaxers such as baclofen or tizanidine.

MalaCards based summary : Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis, also known as human t-cell leukemia virus type 1 associated myelopathy/tropical spastic paraparesis, is related to tropical spastic paraparesis and adult t-cell leukemia. An important gene associated with Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis is HLA-A (Major Histocompatibility Complex, Class I, A), and among its related pathways/superpathways are Allograft rejection and IL12-mediated signaling events. The drugs Miconazole and Pentoxifylline have been mentioned in the context of this disorder. Affiliated tissues include t cells, spinal cord and brain.

Related Diseases for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Diseases related to Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 57)
# Related Disease Score Top Affiliating Genes
1 tropical spastic paraparesis 32.4 CXCR3 FOXP3 IFNL3 IL2RA
2 adult t-cell leukemia 30.7 FOXP3 IL2RA
3 extrinsic allergic alveolitis 30.1 CXCR3 IL2RA
4 multiple sclerosis 30.0 CXCR3 FOXP3 IL2RA
5 myelopathy, htlv-1-associated 12.0
6 human t-cell leukemia virus type 1 11.6
7 retrovirus-associated myelopathy 11.6
8 spastic paraparesis 11.1
9 leukemia 10.6
10 t-cell leukemia 10.6
11 dermatitis 10.6
12 infective dermatitis associated with htlv-1 10.6
13 lymphoma 10.3
14 myopathy 10.3
15 peripheral nervous system disease 10.3
16 neuropathy 10.3
17 neurogenic bladder 10.3
18 amyotrophic lateral sclerosis 1 10.2
19 osteoporosis 10.2
20 pseudopseudohypoparathyroidism 10.2
21 strongyloidiasis 10.2
22 lateral sclerosis 10.2
23 myelitis 10.2
24 pain - chronic 10.2
25 spasticity 10.2
26 caplan's syndrome 10.1 FOXP3 HLA-A
27 thymic dysplasia 10.1 FOXP3 HLA-A
28 anterior uveitis 10.0 HLA-A IL2RA
29 pure red-cell aplasia 10.0 HLA-A IL2RA
30 autoimmune enteropathy 10.0 FOXP3 IL2RA
31 vogt-koyanagi-harada disease 10.0 HLA-A IL2RA
32 alopecia areata 10.0 HLA-A IL2RA
33 chromoblastomycosis 10.0 CXCR3 HLA-A
34 lymphopenia 10.0 FOXP3 IL2RA
35 celiac disease 1 10.0 FOXP3 HLA-A
36 stevens-johnson syndrome/toxic epidermal necrolysis 9.9 CXCR3 HLA-A
37 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 9.9 FOXP3 IL2RA
38 lichen disease 9.9 CXCR3 FOXP3
39 cryoglobulinemia 9.9 CXCR3 IFNL3
40 uveitis 9.9 CXCR3 IL2RA
41 autoimmune disease of central nervous system 9.9 CXCR3 FOXP3
42 intermediate uveitis 9.9 CXCR3 IL2RA
43 autoimmune disease of the nervous system 9.9 CXCR3 FOXP3
44 behcet syndrome 9.9 HLA-A IL2RA
45 oligoarticular juvenile idiopathic arthritis 9.9 CXCR3 IL2RA
46 lymphoproliferative syndrome 2 9.9 CXCR3 IL2RA
47 pulmonary sarcoidosis 9.9 CXCR3 IL2RA
48 diabetes mellitus 9.8 FOXP3 HLA-A IL2RA
49 diabetes mellitus, insulin-dependent 9.8 FOXP3 HLA-A IL2RA
50 common variable immunodeficiency 9.8 FOXP3 IL2RA

Graphical network of the top 20 diseases related to Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis:



Diseases related to Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Symptoms & Phenotypes for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Drugs & Therapeutics for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Drugs for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 45)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3 22916-47-8 4189
2
Pentoxifylline Approved, Investigational Phase 3 6493-05-6 4740
3
Zidovudine Approved Phase 2, Phase 3 30516-87-1 35370
4
Lamivudine Approved, Investigational Phase 2, Phase 3 134678-17-4 60825
5 Immunosuppressive Agents Phase 2, Phase 3
6 Anti-Infective Agents Phase 2, Phase 3,Phase 3,Early Phase 1
7 Calcineurin Inhibitors Phase 2, Phase 3
8 Antifungal Agents Phase 2, Phase 3
9 Immunologic Factors Phase 2, Phase 3
10 Dermatologic Agents Phase 2, Phase 3
11 Cyclosporins Phase 2, Phase 3
12 Antirheumatic Agents Phase 2, Phase 3
13 Vasodilator Agents Phase 3
14 Phosphodiesterase Inhibitors Phase 3
15 Free Radical Scavengers Phase 3
16 Radiation-Protective Agents Phase 3
17 Protective Agents Phase 3
18 Platelet Aggregation Inhibitors Phase 3
19 Antioxidants Phase 3
20 Reverse Transcriptase Inhibitors Phase 2, Phase 3
21 Nucleic Acid Synthesis Inhibitors Phase 2, Phase 3
22 Anti-HIV Agents Phase 2, Phase 3,Early Phase 1
23 Antiviral Agents Phase 2, Phase 3,Early Phase 1
24 Anti-Retroviral Agents Phase 2, Phase 3,Early Phase 1
25 Antimetabolites Phase 2, Phase 3
26
Interferon beta-1a Approved, Investigational Phase 2 145258-61-3 6438354
27
Infliximab Approved Phase 2 170277-31-3
28 Interferon-beta Phase 2
29 interferons Phase 2
30 Adjuvants, Immunologic Phase 2
31 Gastrointestinal Agents Phase 2
32 Immunoglobulins Phase 1
33 Antibodies, Monoclonal Phase 1
34 Antibodies Phase 1
35
Valproic Acid Approved, Investigational Not Applicable 99-66-1 3121
36 HIV Integrase Inhibitors Early Phase 1
37 Integrase Inhibitors Early Phase 1
38 Raltegravir Potassium Early Phase 1
39 Central Nervous System Depressants Not Applicable
40 Antimanic Agents Not Applicable
41 Neurotransmitter Agents Not Applicable
42 Tranquilizing Agents Not Applicable
43 GABA Agents Not Applicable
44 Psychotropic Drugs Not Applicable
45 Anticonvulsants Not Applicable

Interventional clinical trials:

(show all 14)
# Name Status NCT ID Phase Drugs
1 Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Unknown status NCT01343355 Phase 2, Phase 3 Tamibarotene
2 Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Completed NCT00773292 Phase 2, Phase 3 ciclosporin
3 Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases Completed NCT01472263 Phase 3 Pentoxifylline;Placebo
4 Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial Completed NCT00272480 Phase 2, Phase 3 Zidovudine/lamivudine
5 Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) Completed NCT00001785 Phase 2 Recombinant human interferon beta-1a
6 The HAM Infliximab Study Terminated NCT00823641 Phase 2 Infliximab
7 Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Completed NCT00076843 Phase 1 Hu MiK-Beta-1
8 MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis Completed NCT00034723
9 Raltegravir for HAM/TSP Completed NCT01867320 Early Phase 1 Raltegravir
10 A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis Completed NCT00340821
11 Urological Physical Therapy in HTLV-1 With Urinary Symptoms Completed NCT01651819 Not Applicable
12 Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1 Completed NCT01754311
13 Evaluation of Patients With HAM/TSP Recruiting NCT00001778
14 Safety and Efficiency Study of Valproic Acid In HAM/TSP Terminated NCT00519181 Not Applicable Valproic Acid

Search NIH Clinical Center for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Genetic Tests for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Anatomical Context for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

MalaCards organs/tissues related to Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis:

41
T Cells, Spinal Cord, Brain, Prostate, B Cells, Thymus, Nk Cells

Publications for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Articles related to Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis:

(show top 50) (show all 97)
# Title Authors Year
1
Role of Integrin Signaling Activation on the Development of Human T-Cell Leukemia VIrus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-infected CD4+ T Cell Transmigrating Activity into the Tissues. ( 29400072 )
2018
2
Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010). ( 29554087 )
2018
3
Early Juvenile HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): Study of 25 Patients. ( 29912303 )
2018
4
Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity. ( 30090093 )
2018
5
Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. ( 30341468 )
2018
6
Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil. ( 30466392 )
2018
7
Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). ( 28378248 )
2017
8
Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. ( 27894665 )
2017
9
Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 28420387 )
2017
10
Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients. ( 28101786 )
2017
11
The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 29202792 )
2017
12
Early Onset of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T-cell Leukemia/Lymphoma (ATL): Systematic Search and Review. ( 28582585 )
2017
13
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). ( 28095504 )
2017
14
Mediators Go Together: High Production of CXCL9, CXCL10, IFN-γ, and TNF-α in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. ( 28648091 )
2017
15
The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis. ( 27845163 )
2017
16
Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. ( 27028551 )
2016
17
HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression. ( 27871430 )
2016
18
Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. ( 25820278 )
2015
19
Hypometabolism of watershed areas of the brain in HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 26156876 )
2015
20
Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon. ( 26169165 )
2015
21
Common I^-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 26283355 )
2015
22
Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study. ( 25820277 )
2015
23
Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8(+) T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma. ( 26077665 )
2015
24
HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 27188208 )
2015
25
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. ( 26174324 )
2015
26
HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene. ( 26609200 )
2015
27
Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). ( 25884435 )
2015
28
Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 25470342 )
2015
29
A Peruvian family with a high burden of HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 26392440 )
2015
30
Interferon beta-1a treatment in HTLV-1-associated myelopathy/tropical spastic paraparesis: a case report. ( 25229227 )
2014
31
Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 24802839 )
2014
32
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis. ( 24472094 )
2014
33
IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers. ( 25233462 )
2014
34
Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). ( 25227931 )
2014
35
Genes Related to Antiviral Activity, Cell Migration, and Lysis Are Differentially Expressed in CD4(+) T Cells in Human T Cell Leukemia Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis Patients. ( 24041428 )
2013
36
Invasion of histiocytic sarcoma into the spinal cord of HTLV-1 tax transgenic mice with HTLV-1-associated myelopathy/tropical spastic paraparesis-like disease. ( 23924924 )
2013
37
Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). ( 23022356 )
2013
38
Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis. ( 23943469 )
2013
39
Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil. ( 23932323 )
2013
40
Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection. ( 23278610 )
2013
41
Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran. ( 23568138 )
2013
42
CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 24130912 )
2013
43
Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression. ( 23756056 )
2013
44
Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. ( 23651542 )
2013
45
Contribution of Galvanic Vestibular Stimulation for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. ( 24285967 )
2013
46
Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1. ( 22170554 )
2012
47
Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives. ( 23198155 )
2012
48
Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis. ( 22720101 )
2012
49
Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients. ( 22990976 )
2012
50
Short communication an interferon-I^ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population. ( 21453202 )
2011

Variations for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Expression for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Search GEO for disease gene expression data for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis.

Pathways for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

GO Terms for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

Cellular components related to Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 8.8 CXCR3 HLA-A IL2RA

Biological processes related to Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.54 CXCR3 HLA-A IL2RA
2 negative regulation of inflammatory response GO:0050728 9.4 FOXP3 IL2RA
3 negative regulation of T cell proliferation GO:0042130 9.32 FOXP3 IL2RA
4 T cell homeostasis GO:0043029 9.26 FOXP3 IL2RA
5 regulation of regulatory T cell differentiation GO:0045589 9.16 FOXP3 IL2RA
6 negative regulation of immune response GO:0050777 8.96 FOXP3 IL2RA
7 negative regulation of lymphocyte proliferation GO:0050672 8.62 FOXP3 IL2RA

Sources for Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....